Israeli coronavirus vaccine developers target summer human trials
Vaccine researchers at MigVax secured a $12 million funding boost on Wednesday, led by investment platform OurCrowd
MIGAL researchers working vigorously to find a new coronavirus vaccine(photo credit: LIOR JOURNO)